An Introduction to Paediatric Endocrinology
Paediatric endocrinology is a complex field incorporating many conditions such as over or under activity of the pituitary, thyroid and adrenal glands, type 1 diabetes and metabolic bone disease that affect the paediatric population. Collaboration between a multidisciplinary team of paediatric endocrinology specialists, adult endocrinologists and specialist nurses is important to ensure coordinated and comprehensive care.
Browse our gallery of video highlights and short articles from the conference hub, providing the latest expert insights from major conferences and peer-reviewed articles from the journal portfolio.
Paediatric Endocrinology Content
Clinical management strategies in achondroplasia: Current landscape and new horizons
Watch three leading experts explore how the pathophysiology of achondroplasia is being targeted by new and emerging pharmacotherapies to restore endochondral ossification. A roadmap to optimized current and future clinical management is also outlined.
- Know the importance and clinical implications of FGFR3 mutations underlying achondroplasia
- Evaluate the existing clinical challenges to effective patient management
- Understand how new therapies may impact clinical management and patient outcomes in future
Get Excited for ESPE 2020!
ESPE European Society for Paediatric Endocrinology Hear from those who are helping shape the ESPE 2020 experience! Find out more at: www.eurospe.org/meetings/2020/espe2020/ and see why you need to attend this year’s Meeting in Liverpool from the 10 – 12 September 2020.
Efficacy and Safety Evaluation of Human Growth Hormone Therapy in Patients with Idiopathic Short Stature in Korea – A Randomised Controlled Trial
European Endocrinology. 2020;16(1):54-9
Growth hormone (GH) is approved in children to treat growth failure in several indications including GH deficiency, Turner syndrome and short children born small for gestational age,1 and is approved in the USA but not in Europe for the treatment of idiopathic short stature (ISS).2 ISS describes short children with normal GH secretion, with height >2 standard […]
Continuing the conversation in growth hormone disorders – how do we progress towards personalized medicine for patients with acromegaly?
Stay up to date with the latest developments in the diagnosis, management and treatment of patients with acromegaly with our expert summary from the European Congress of Endocrinology (ECE) in Lyon, France, 18–21 May 2019. Part 1: Watch internationally renowned expert Prof. John Wass review key data from ECE2019 Part 2: Choose from leading experts who discuss what the data findings mean for global and regional practice
- Interpret the latest information and guidance about the need for early diagnosis and monitoring of acromegaly
- Recall the most recent data around patient and disease characteristics, including the importance of recognizing comorbidities, in order to select the optimal treatment strategy for each individual patient with acromegaly
- Recognize the role of medical treatment options for acromegaly and best practice for patient management using a multidisciplinary team approach
Continuing the conversation in paediatric endocrinology – how do the latest advances in understanding biology translate to improved patient care?
Stay up to date with the latest developments in the biology, diagnosis and treatment of paediatric patients with growth hormone disorders with our touchCONGRESS Webinar and Expert Interviews from the European Society for Paediatric Endocrinology (ESPE) Congress in Vienna, Austria, 19–21 September 2019. Part 1: Watch internationally renowned expert Prof. Martin Savage review key data from ESPE 2019 Part 2: Choose from leading experts who discuss what the data finding mean for global and reginal practice
- Recall the latest advances in understanding the biology of paediatric growth disorders
- Interpret the latest data for the diagnosis and management of paediatric growth disorders and their impact on daily clinical practice
- Recognize the importance of personalized medicine on clinical outcomes
touchCONGRESS Expert Interviews
Leading the conversation in paediatric endocrinology
Watch a series of internationally renowned clinical specialists discuss the clinical landscape for severe primary IGF-1 deficiency (SPIGFD), including data from the European Society for Paediatric Endocrinology (ESPE) 2018 Congress in Athens, Greece, 27–29 September 2018.
- Share your increased awareness and understanding of SPIGFD
- Contribute to the optimization of diagnosis in paediatric growth hormone insensitivity syndromes
- Demonstrate increased familiarity and confidence with early treatment of SPIGFD
- Drive improved patient outcomes through sharing of best practice.
A New Paediatric Diabetes Knowledge Test – M-WIKAD Development and Factor Analysis
European Endocrinology. 2019;15(1):Epub ahead of print DOI: https://doi.org/10.17925/EE.2019.15.1.1
The purpose of this study was to develop a measure of type 1 diabetes mellitus (T1DM) knowledge that is aimed at youth and is based on contemporary management standards. The Mercy What I Know About Diabetes (M-WIKAD) is a 19-item questionnaire that is a valid measure of diabetes knowledge in youth with T1DM. Factor […]
Thomas Danne, EASD 2018 – latest advances in paediatric diabetes
Professor Danne explores recent developments in paediatric diabetes. Questions: 1. What are the latest advances in paediatric diabetes care? (0:12) 2. What are the current developments in new insulins, glucose sensors and insulin pumps? (0:50) 3. What are your highlights of EASD 2018 so far, and which presentations or data are you most interested in? […]
Male Central Hypogonadism in Paediatrics – the Relevance of Follicle-stimulating Hormone and Sertoli Cell Markers
European Endocrinology, 2018;14(2):67–71 DOI: https://doi.org/10.17925/EE.2018.14.2.67
In the adult male, hypogonadism is usually defined by the failure of the testis to produce physiological concentrations of testosterone and/or a normal number of spermatozoa.1 When due to abnormalities of the hypothalamic-pituitary axis, the condition is referred to as hypogonadotropic or central hypogonadism, whereas those due to testicular defects are called hypergonadotropic or primary […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!